[Tracking the changes in the HDL cholesterol levels at different time intervals after acute myocardial infraction]

Prilozi
|March 1, 2005
PubMed

Insights

Low high-density lipoprotein (HDL) cholesterol increases coronary event risk. This study tracked HDL levels in ST-elevation myocardial infarction (STEMI) patients, finding initial levels are lowest within 24 hours and normalize over 60-90 days.

Area of Science:

  • Cardiology
  • Biochemistry
  • Clinical Medicine

Context:

  • Low high-density lipoprotein (HDL) cholesterol is a risk factor for coronary events in patients with coronary artery disease (CAD).
  • Serum lipid levels measured within 24 hours of acute myocardial infarction (AMI) represent basal levels, subject to post-event fluctuations.
  • Understanding HDL cholesterol dynamics post-AMI is crucial for risk stratification and management.

Purpose:

  • To investigate changes in HDL cholesterol levels in patients with ST-elevation acute myocardial infarction (STEMI) over time.
  • To determine the optimal time for measuring HDL cholesterol in STEMI patients to establish baseline values.
  • To assess the post-event recovery and potential normalization of HDL cholesterol levels.

Summary:

  • A follow-up study monitored HDL cholesterol in 230 middle-aged STEMI patients at various intervals (24 hours, 3-7 days, 10-14 days, 30-60 days, 60-90 days).
  • Results indicated that STEMI patients exhibited lower initial HDL cholesterol, with a tendency to decrease further by day three, followed by gradual normalization and even surpassing baseline levels by 60-90 days.
  • The study suggests that the first 24 hours post-STEMI are optimal for baseline HDL cholesterol measurement due to significant initial decreases.

Impact:

  • Establishes the first 24 hours post-STEMI as the critical window for baseline HDL cholesterol assessment.
  • Provides evidence for the dynamic changes in HDL cholesterol following myocardial infarction.
  • Informs clinical practice regarding the timing of lipid profile measurements for accurate risk assessment in STEMI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...